Preclinical Pharmacokinetics of 4-Hydroxy Isoleucine Using Lc–Ms/Ms: A Potential Polycystic Ovary Syndrome Phytopharmaceutical Therapeutics

References

• Tata B , MimouniNEH, BarbotinALet al. Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood. Nat. Med.24(6), 834–846 (2018).
   PubMed Web of Science ®Google Scholar
• Agrawal S , BisenAC, SanapSNet al. LC–MS/MS based quantification method of steroidal biomarkers in polycystic ovary syndrome induced rat. J. Pharm. Biomed. Anal. (2023). 10.1016/j.jpba.2023.115484
   Web of Science ®Google Scholar
• Tehrani FR , SimbarM, TohidiMet al. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod. Biol. Endocrinol.9(1), 39 (2011).
   Google Scholar
• Agrawal S , BisenAC, BiswasAet al. Simultaneous pharmacokinetic assessment of phytopharmaceuticals in fenugreek extract using LC–MS/MS in Sprague–Dawley rats. Biomed. Chromatogr.37(5), e5600 (2023).
   Web of Science ®Google Scholar
• Jetté L, Harvey L, Eugeni K, Levens N. 4-Hydroxyisoleucine: a plant-derived treatment for metabolic syndrome. Curr. Opin. Investig. Drugs. 10(4) 353–358 (2009).
   Google Scholar
• Tariq L . Comparative Insilico Analysis of Fenugreek and Flaxseed for Drug Development in Polycystic Ovary Syndrome.Capital University of Science & Technology, Islamabad, Pakistan, 1–121 (2022). https://thesis.cust.edu.pk/UploadedFiles/LaraibTariq-MBS203029.pdf
   Google Scholar
• El Refaeey A , SelemA, BadawyA. Combined coenzyme Q10 and clomiphene citrate for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome. Reprod. Biomed. Online29(1), 119–124 (2014).
   Web of Science ®Google Scholar
• Daniilidis A , DinasK. Long term health consequences of polycystic ovarian syndrome: a review analysis. Hippokratia.13(2), 90–92 (2009).
   PubMed Web of Science ®Google Scholar
• Younesy S , AmiraliakbariS, EsmaeiliSet al. Effects of fenugreek seed on the severity and systemic symptoms of dysmenorrhea. J. Reprod. Infertil.15(1), 41–48 (2014).
   PubMedGoogle Scholar
• Chopra S , AhmadFJ, KharRKet al. Validated high-performance thin-layer chromatography method for determination of trigonelline in herbal extract and pharmaceutical dosage form. Anal. Chim. Acta.577(1), 46–51 (2006).
   Web of Science ®Google Scholar
• Mohamadi N , SharififarF, AnsariMet al. Pharmacokinetic profile of diosgenin and trigonelline following intravenous and oral administration of fenugreek seed extract and pure compound in rabbit. J. Asian Nat. Prod. Res.23(5), 466–477 (2021).
   PubMed Web of Science ®Google Scholar
• Snehlata HS , PayalDR. Fenugreek (Trigonella foenum-graecum L.): an overview. Int. J. Curr. Pharm. Rev. Res.2(4), 169–187 (2011).
   Google Scholar
• Yoshinari O , SatoH, IgarashiK. Anti-diabetic effects of pumpkin and its components, trigonelline and nicotinic acid, on Goto-Kakizaki rats. Biosci. Biotechnol. Biochem.73(5), 1033–41 (2009).
   PubMed Web of Science ®Google Scholar
• Shabbeer S , SobolewskiM, AnchooriRKet al. Fenugreek a naturally occurring edible spice as an anticancer agent. Cancer Biol. Ther.8(3), 272–278 (2009).
   PubMed Web of Science ®Google Scholar
• Ribes G , SauvaireY, DaCosta Cet al. Antidiabetic effects of subfractions from fenugreek seeds in diabetic dogs. Proc. Soc. Exp. Biol. Med.182(2), 159–166 (1986).
   PubMed Web of Science ®Google Scholar
• Wani SA , KumarP. Fenugreek: a review on its nutraceutical properties and utilization in various food products. J. Saudi Soc. Agri. Sci.17(2), 97–106 (2018). 10.1016/j.jssas.2016.01.007
   Google Scholar
• Swaroop A , JaipuriarAS, GuptaSKet al. Efficacy of a novel fenugreek seed extract (Trigonella foenum-graecum, furocyst™) in polycystic ovary syndrome (PCOS). Int. J. Med. Sci.12(10), 825–831 (2015).
   Web of Science ®Google Scholar
• Zhou J , ChanL, ZhouS. Trigonelline: a plant alkaloid with therapeutic potential for diabetes and central nervous system disease. Curr Med Chem.19(21), 3523–3531 (2012).
   PubMed Web of Science ®Google Scholar
• Sharma RD , RaghuramTC. Hypoglycaemic effect of fenugreek seeds in non-insulin dependent diabetic subjects. Nutr. Res.10(7), 731–739 (1990).
   Web of Science ®Google Scholar
• Wadhwa G , KrishnaKV, TaliyanRet al. A novel UPLC–MS/MS method for simultaneous quantification of trigonelline, 4-hydroxyisoleucine, and diosgenin from Trigonella foenum-graecum extract: application to pharmacokinetic study in healthy and type 2 diabetic rats. Biomed. Chromatogr.36(2), 1–11 (2022).
   Web of Science ®Google Scholar
• Narender T , PuriA, Shwetaet al. 4-Hydroxyisoleucine an unusual amino acid as antidyslipidemic and antihyperglycemic agent. Bioorganic Med. Chem. Lett.16(2), 293–296 (2006).
   PubMed Web of Science ®Google Scholar
• Sergent D , WangQ, SasakiNA, OuazzaniJ. Synthesis of hydantoin analogues of (2S,3R,4S)-4-hydroxyisoleucine with insulinotropic properties. Bioorganic Med. Chem. Lett.18(15), 4332–4335 (2008).
   Web of Science ®Google Scholar
• Broca C , GrossR, PetitPet al. 4-Hydroxyisoleucine: experimental evidence of its insulinotropic and antidiabetic properties. Am. J. Physiol. - Endocrinol. Metab.277(4), E617–E623 (1999).
   Web of Science ®Google Scholar
• Singh R , YadavKS, PrajapatiRet al. 4-HIL mitigates type-2 diabetic complications through inhibiting inflammation and Nrf2 mediated oxidative stress in rats. Phytomedicine Plus.2(1), DOI: 10.1016/j.phyplu.2021.100141 (2022).
   Google Scholar
• Sauvaire Y , PetitP, BrocaCet al. 4-Hydroxyisoleucine: a novel amino acid potentiator of insulin secretion. Diabetes.47(2), 206–210 (1998).
   PubMed Web of Science ®Google Scholar
• Wadhwa G , KrishnaKV, TaliyanRet al. Pre-clinical pharmacokinetic and pharmacodynamic modelling study of 4-hydroxyisoleucine using validated ultra-performance liquid chromatography-tandem mass spectrometry. RSC Adv.10(10), 5525–5532 (2020).
   Web of Science ®Google Scholar
• Gowtham L , UjjalkumarD, MokshaLet al. Hydrophilic interaction LC–MS/MS method to avoid endogenous interference in the analysis of 4-hydroxy isoleucine from dietary supplementation of fenugreek. J. Sep. Sci.45(6), 1210–1221 (2022).
   Web of Science ®Google Scholar
• Imre S , VlaseL, MunteanDL. Bioanalytical method validation. Rev. Rom. Med. Lab.10(1), 13–21 (2008).
   Google Scholar
• Bisen AC , SanapSN, BiswasAet al. AQbD-led simple and sensitive RP-UHPLC method for simultaneous determination of moxifloxacin, voriconazole, and pirfenidone: An application to pharmaceutical analysis. Biomed. Chromatogr. (2023). 10.1002/bmc.5681
   Google Scholar
• Gurav S , PoliceA, ZainuddinMet al. Development and validation of a highly sensitive LC–ESI-MS/MS method for the determination of Orteronel® (TAK-700) in rat plasma: application to a pharmacokinetic study. Bioanalysis4(12), 1471–1480 (2012).
   PubMed Web of Science ®Google Scholar
• Sanap SN , MishraA, BisenACet al. Simultaneous determination of fluconazole and ofloxacin in rabbit tear fluid by LC–MS/MS: application to ocular pharmacokinetic studies. J. Pharm. Biomed. Anal. DOI: 10.1016/j.jpba.2021.114463 (2022). 10.1016/j.jpba.2021.114463
   Google Scholar
• Sanap SN , BisenAC, AgrawalSet al. Liquid chromatography-tandem mass spectrometry method for simultaneous assessment of ofloxacin and dexamethasone in ocular biofluids: application to ocular pharmacokinetic studies. Sep. Sci. Plus.5(11), 593–601 (2022).
   Web of Science ®Google Scholar
• Sanap SN , AgrawalS, BiswasAet al. Simultaneous assessment of ciprofloxacin and dexamethasone in ocular tear fluid by LC–MS/MS: application to a pharmacokinetic study in rabbits. Chinese J. Anal. Chem.51(6), 1–8 (2023).
   Web of Science ®Google Scholar
• Ramakrishna R , BhateriaM, SinghRet al. Plasma pharmacokinetics, bioavailability and tissue distribution of agnuside following per oral and intravenous administration in mice using liquid chromatography tandem mass spectrometry. J. Pharm. Biomed. Anal.125, 154–164 (2016). 10.1016/j.jpba.2016.02.047
   Web of Science ®Google Scholar
• Matuszewski BK , ConstanzerML, Chavez-EngCM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC–MS/MS. Anal. Chem.75(13), 3019–3030 (2003).
   PubMed Web of Science ®Google Scholar
• Bisen AC , AgrawalS, SanapSNet al. Simultaneous estimation of voriconazole, moxifloxacin, and pirfenidone in rabbit lacrimal matrix using LC–MS/MS: an application to preclinical ocular pharmacokinetics. Anal. Methods.15, 2234–2243 (2023).
   PubMed Web of Science ®Google Scholar
• Bhateria M , RamakrishnaR, PuttrevuSKet al. Analysis of bacopaside I in biomatrices using liquid chromatography-tandem mass spectrometry: pharmacokinetics and brain distribution in Swiss-albino mice. J. Pharm. Biomed. Anal.125, 101–109 (2016). 10.1016/j.jpba.2016.03.002
   Web of Science ®Google Scholar
• Chhonker YS , ChandasanaH, KumarDet al. Pharmacokinetic and metabolism studies of rohitukine in rats by high performance liquid-chromatography with tandem mass spectrometry. Fitoterapia.97, 34–42 (2014).
   Web of Science ®Google Scholar
• Chanda S , BashirM, BabbarSet al. In vitro hepatic and skin metabolism of capsaicin. Drug Metab. Dispos.36(4), 670–675 (2008).
   PubMed Web of Science ®Google Scholar
• Brown RP , DelpMD, LindstedtSLet al. Physiologically based pharmacokinetic models protection agency; V. Toxicol. Ind. Health.13(4), 407–484 (1997).
   PubMed Web of Science ®Google Scholar
• Bhateria M , RamakrishnaR, PuttrevuSKet al. Pre-clinical investigation of plasma pharmacokinetics and biodistribution of a novel antithrombotic agent S002-333 in mice using LC–MS/MS. J. Chromatogr. B Anal. Technol. Biomed. Life Sci.1031, 154–162 (2016). 10.1016/j.jchromb.2016.07.030
   PubMed Web of Science ®Google Scholar
• Laxman TS , PuttrevuSK, PradhanRet al. Pharmacokinetics, metabolism, bioavailability, tissue distribution and excretion studies of 16α-hydroxycleroda-3, 13(14) Z-dien-15, 16-olide—a novel HMG-CoA reductase inhibitor. Naunyn. Schmiedebergs. Arch. Pharmacol.391(9), 965–973 (2018).
   Web of Science ®Google Scholar
• Verma SK , BiswasA, KumarMet al. Preclinical pharmacokinetics, CYP phenotyping, and tissue distribution study of novel anti-breast cancer candidate S-011-1559. Xenobiotica52(5), 476–487 (2022).
   PubMed Web of Science ®Google Scholar